Patent Search

By Author: Jason Benson
Total Articles: 4
Comment this article

IP Australia is looking to get feedback on how the development patent method is working.

Ever since 2001, The country grants two kinds of patent: the standard patent with a normal time period of 20 yrs or an invention patent with a span around 8 years.

Ann advancement patent require show primarily an innovative step over the prior art to be legitimate. As per the Full Court in Delnorth, this requires a big improvement that the particular person knowledgeable in the art should grasp makes a material factor to exactly how the item / method functions. As the Whole Court accepted, this is nothing like the original step demand for a standard patent. See moreover the SNF case.

As stated by IP Australia’s web-site:

Considering the fact that the Delnorth (09) decision in the Fed Court, somewhat evident minor upgrades to innovations has been patentable. There is certainly a special growth of advancement patent applications for particular systems. There is some indication that larger companies could possibly be utilizing the innovation patent process to extend the life of their patents and deliberately targeting ...
... competitors.

ACIP is currently undertaking a review into the development patent process overall. The consulting paper for this (IP Australia’s) review clarifies:

The Analysis Council on Intellectual Property is now executing overview of the Advancement Patent system altogether. In the mid term, this provides valuable observations and suggestions for enhancements.

For a while, however, there is certainly a urgent need to discuss emerging dangers of the Innovation Patent system getting used in methods which might bring about undue expenditure to consumers and to companies that compete with owners of Development Patents. As an example, you can find a need to make sure that Innovation Patents do not unsuitably expand the life of drug manufacturing patents and holdup the introduction of less expensive generic medicines, producing increased costs to consumers and also a gain in government expenditure through the Pharmaceutical Benefits Strategy.

Consequently, the Government proposes to personalize the Patents Act 1990 to boost the tolerance for uniqueness to the same level as for Standard Patents (Attachment A pertains). This strategy is conforming to the 2nd tier patent systems working in countries including Germany and also Japan.

Posted online by Intellectual Property Firm